Compare Medpace Holdings Inc (MEDP) vs Procter & Gamble Co (PG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Procter & Gamble Co — how do they compare? Medpace Holdings Inc trades at $530.22 (market cap $15.08B), while Procter & Gamble Co trades at $148.12 (market cap $347.26B). The key difference: Procter & Gamble Co is far larger — about 23× Medpace Holdings Inc's market cap, and Procter & Gamble Co pays a 2.92% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | PG | |
|---|---|---|
Market Cap | $15.08B | $347.26B |
Sector | Technology | Consumer Staples |
52-Week High | $620.59 | $167.18 |
52-Week Low | $308.88 | $138.10 |
Enterprise Value | $14.55B | $372.74B |
Volume | — | 6,423,436 |
Dividend Yield | — | 2.92% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Procter & Gamble (PG) trades at $148.12, down 1.23% on the day, with a bullish technical outlook supported by moving averages and key resistance at $150. The company shows steady revenue growth, with 2025 revenue at $84.28 billion and net income of $15.97 billion, alongside consistent quarterly earnings beats. Recent news highlights PG's dividend reliability and strategic partnerships, such as the WNBA deal announced on April 7, 2026.
PG offers a stable investment with a strong dividend history and moderate growth, but faces risks from premium valuations and economic sensitivity. Analyst consensus is bullish with a $161.71 price target, though near-term upside may be limited by high P/E and P/S ratios relative to peers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
